Acadia Pharmaceuticals
ACAD
ACAD
212 hedge funds and large institutions have $3.07B invested in Acadia Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 94 increasing their positions, 62 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
11% less call options, than puts
Call options by funds: $88.5M | Put options by funds: $99.7M
11% less capital invested
Capital invested by funds: $3.47B → $3.07B (-$398M)
Holders
212
Holding in Top 10
4
Calls
$88.5M
Puts
$99.7M
Top Buyers
| 1 | +$104M | |
| 2 | +$67M | |
| 3 | +$53.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$49M |
| 5 |
O
OrbiMed
New York
|
+$39.2M |
Top Sellers
| 1 | -$41M | |
| 2 | -$37.9M | |
| 3 | -$29.9M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$22.8M |
| 5 |
BAMCO Inc
New York
|
-$22.7M |